2,393
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Phloretin inhibited the pathogenicity and virulence factors against Candida albicans

, , , &
Pages 2420-2431 | Received 18 Mar 2021, Accepted 19 May 2021, Published online: 24 Jun 2021

References

  • Lombardi A, Ouanounou A. Fungal infections in dentistry: clinical presentations, diagnosis, and treatment alternatives. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(5):533–546.
  • Poulain D. Candida albicans, plasticity and pathogenesis. Crit Rev Microbiol. 2015;41(2):208–217.
  • Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br Dent J. 2017;223(9):675–681.
  • Quindós G, Gil-Alonso S, Marcos-Arias C, et al. Therapeutic tools for oral candidiasis: current and new antifungal drugs. Med Oral Patol Oral Cir Bucal. 2019;24(2):e172–e80.
  • Rodrigues CF, Rodrigues ME, Henriques MCR. Promising alternative therapeutics for oral candidiasis. Curr Med Chem. 2019;26(14):2515–2528.
  • Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol. 2016;34(4):487–494.
  • Dadar M, Tiwari R, Karthik K, et al. Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control - An update. Microb Pathog. 2018;117:128–138.
  • Kadosh D. Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans. Curr Opin Microbiol. 2019;52:27–34.
  • Ansari MA, Fatima Z, Hameed S. Sesamol: a natural phenolic compound with promising anticandidal potential. J Pathog. 2014;2014:895193.
  • Mendes RA, Silva BLS E, Takeara R, et al. Probing the antioxidant potential of phloretin and phlorizin through a computational investigation. J Mol Model. 2018;24(4):101.
  • Cheon D, Kim J, Jeon D, et al. Target proteins of phloretin for its anti-inflammatory and antibacterial activities against -induced skin infection. Molecules. 2019;24(7):1319.
  • Choi BY. Biochemical basis of anti-cancer-effects of phloretin-A natural dihydrochalcone. Molecules. 2019;24(2):278.
  • Adil M, Baig MH, Rupasinghe HPV. Impact of citral and phloretin, alone and in combination, on major virulence traits of streptococcus pyogenes. Molecules. 2019;24(23):4237.
  • Lopes LAA, dos Santos Rodrigues JB, Magnani M, et al. Inhibitory effects of flavonoids on biofilm formation by Staphylococcus aureus that overexpresses efflux protein genes. Microb Pathog. 2017;107:193–197.
  • Raorane CJ, Lee J-H, Kim Y-G, et al. Antibiofilm and antivirulence efficacies of flavonoids and curcumin against acinetobacter baumannii. Front Microbiol. 2019;10:990.
  • Lee J-H, Regmi SC, Kim J-A, et al. Apple flavonoid phloretin inhibits Escherichia coli O157: h7biofilm formation and ameliorates colon inflammation in rats. Infect Immun. 2011;79(12):4819–4827.
  • Shim SH, Jo SJ, Kim JC, et al. Control efficacy of phloretin isolated from apple fruits against several plant diseases. Plant Pathology J. 2010;26(3):280–285.
  • Clinical L Reference Method for Broth Dilution antifungal susceptibility testing of yeasts, 3rd edition, approved standard M27-A3. 2008.
  • Chevalier M, Doglio A, Rajendran R, et al. Inhibition of adhesion-specific genes by Solidago virgaurea extract causes loss of Candida albicans biofilm integrity. J Appl Microbiol. 2019;127(1):68–77.
  • Yu H, Liu X, Wang C, et al. Assessing the potential of four cathelicidins for the management of mouse candidiasis and Candida albicans biofilms. Biochimie. 2016;121:268–277.
  • Wang B, You J, JB K, et al. Polyketide glycosides from Bionectria ochroleuca inhibit Candida albicans biofilm formation. J Nat Prod. 2014;77(10):2273–2279.
  • Tan Y, Cheng Q, Yang H, et al. Effects of ALA-PDT on biofilm structure, virulence factor secretion, and QS in Pseudomonas aeruginosa. Photodiagnosis Photodyn Ther. 2018;24:88–94.
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.
  • Seleem D, Benso B, Noguti J, et al. In vitro and in vivo antifungal activity of lichochalcone-A against candida albicans biofilms. PLoS ONE. 2016;11(6):e0157188.
  • Santana IL, Gonçalves LM, de Vasconcellos AA, et al. Dietary carbohydrates modulate Candida albicans biofilm development on the denture surface. PLoS ONE. 2013;8(5):e64645.
  • Pierce CG, Chaturvedi AK, Lazzell AL, et al. A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance. NPJ Biofilms Microbiomes. 2015;1(1):15012.
  • Takakura N, Sato Y, Ishibashi H, et al. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol. 2003;47(5):321–326.
  • Geohagen BC, Korsharskyy B, Vydyanatha A, et al. Phloretin cytoprotection and toxicity. Chem Biol Interact. 2018;296:117–123.
  • Wu M, Li P, An Y, et al. Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol Res. 2019;150:104489.
  • Gaucher M, Dugé De Bernonville T, Lohou D, et al. Histolocalization and physico-chemical characterization of dihydrochalcones: insight into the role of apple major flavonoids. Phytochemistry. 2013;90:78–89.
  • Vandenbosch D, Braeckmans K, Nelis HJ, et al. Fungicidal activity of miconazole against Candida spp. biofilms. J Antimicrob Chemother. 2010;65(4):694–700.
  • Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, et al. Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Curr Opin Microbiol. 2019;52:1–6.
  • Tsui C, Kong EF, Jabra-Rizk MA. Pathogenesis of Candida albicans biofilm. Pathog Dis. 2016;74(4):ftw018.
  • Manoharan RK, Lee J-H, Kim Y-G, et al. Alizarin and chrysazin inhibit biofilm and hyphal formation by Candida albicans. Front Cell Infect Microbiol. 2017;7:447.
  • Smiljković M, Kostić M, Stojković D, et al. Could flavonoids compete with synthetic azoles in diminishing Candida albicans infections? A comparative review based on in vitro studies. Curr Med Chem. 2019;26(14):2536–2554.
  • Peralta MA, Ortega MG, Cabrera JL, et al. The antioxidant activity of a prenyl flavonoid alters its antifungal toxicity on Candida albicans biofilms. Food Chem Toxicol. 2018;114:285–291.
  • Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–128.
  • Qiao Y-N, Jin X-Y, Zhou J-C, et al. Terpenoids from the liverwort plagiochila fruticosa and their antivirulence activity against Candida albicans. J Nat Prod. 2020;83(6):1766–1777.
  • Vaňková E, Kašparová P, Dulíčková N, et al. Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases and hemolytic activity. FEMS Yeast Res. 2020;20(3):foaa020.
  • Abirami G, Alexpandi R, Durgadevi R, et al. Inhibitory effect of morin against candida albicans pathogenicity and virulence factor production: an in vitro and in vivo approaches. Front Microbiol. 2020;11:561298.
  • Andrade JT, Santos FRS, Lima WG, et al. Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents. J Antibiot (Tokyo). 2018;71(8):702–712.